Sexxpot
A low-THC indica-dominant strain marketed by HSO as an aphrodisiac, with branding that outruns the evidence.
Sexxpot is a real Humboldt Seed Organization release with a memorable hook: it's pitched as 'cannabis for women' and a sex enhancer. The plant itself is unremarkable in a good way — a short, mostly indica hybrid with modest THC (often 14-16%) that some users find relaxing. The aphrodisiac claim, however, has no controlled clinical evidence behind it. Cannabis and libido is a complicated, dose-dependent topic, and no study has ever tested this specific cultivar. Treat the marketing as marketing.
Overview
Sexxpot is a cultivar released by Humboldt Seed Organization (HSO), a Northern California breeder, and was publicly promoted around 2015 as a strain designed with female consumers in mind [1][2]. The marketing centered on a deliberately moderate THC level — unusual for a market that was racing toward 25%+ flower — and on claims of enhanced sensuality and libido. Plants are short, bushy, and finish relatively quickly, which is consistent with an indica-leaning hybrid. Beyond HSO's own materials and a handful of press write-ups, there is very little independent characterization of this cultivar Weak / limited.
Chemistry
Lab data on Sexxpot is sparse and not aggregated in any public chemovar database that we can verify. HSO and resellers typically advertise THC in the 14-16% range with negligible CBD (<1%), placing it firmly in the THC-dominant chemovar (Type I) category [1] Weak / limited.
No peer-reviewed terpene profile for Sexxpot has been published. Retail and seedbank pages variously list myrcene, caryophyllene, or limonene as dominant, but these are not backed by traceable lab certificates No data. The popular '0.5% myrcene threshold determines indica couch-lock' claim sometimes attached to strains like this is folklore, not science — it traces to a self-published source, not peer-reviewed research [3] Disputed.
Reported effects
User reports describe a relaxed, mildly euphoric, low-ceiling high consistent with its modest THC content Anecdote. HSO markets it specifically as enhancing arousal and intimacy [1].
The honest picture on cannabis and sex: survey data suggests many users report improved sexual experience with cannabis, but this is self-report, dose- and context-dependent, and not strain-specific [4][5] Weak / limited. There is no clinical trial of Sexxpot, no controlled comparison against other cultivars, and no known mechanism that would make this particular cross uniquely aphrodisiac. Any 'female-specific' or 'libido-boosting' branding should be read as marketing positioning, not pharmacology No data. As with any THC product, higher doses can do the opposite — increase anxiety and reduce arousal [4] Weak / limited.
Lineage
HSO has described Sexxpot's parentage only loosely in public materials, generally framing it as an indica-dominant selection from their breeding stock [1]. Specific parent cultivars have not been disclosed in a verifiable way, and various third-party seed indexes list contradictory or unsourced pedigrees Disputed.
For a strain whose entire identity is built on a marketing concept rather than a famous cut, this is not unusual — but it does mean any confident lineage chart you see online for Sexxpot should be treated skeptically unless HSO confirms it directly.
Cultivation basics
Sexxpot is generally described as beginner-friendly: short stature (often under a meter indoors), tolerant of training, and a flowering time around 8-9 weeks [1][2] Weak / limited. Indoor yields reported by the breeder fall in the moderate range (~400-450 g/m² under good conditions); outdoor harvests in temperate Northern Hemisphere climates typically finish in late September to early October.
The plant's compact structure makes it a reasonable candidate for small tents, SCROG, or sea-of-green setups. None of these cultivation parameters are independently verified outside breeder and reseller claims, so treat numbers as ballpark rather than guarantees.
Marketing vs. reality
Sexxpot is the clearest example in the modern catalog of a strain sold primarily on a narrative rather than a chemotype. The 'cannabis for women' angle drew real press coverage in 2015 [2], and the low-THC positioning was, to HSO's credit, ahead of a trend toward more moderate products.
But several common claims attached to this strain don't hold up:
- 'Designed for women.' There is no biological basis for a cannabis cultivar being sex-specific. Sex differences in cannabis response exist [6], but they are not addressable by breeding a particular hybrid No data.
- 'Aphrodisiac strain.' No clinical evidence specific to Sexxpot. General cannabis-and-sex survey data is suggestive but mixed and confounded [4][5] Weak / limited.
- 'Indica = relaxing because of myrcene.' The indica/sativa label is a poor predictor of effects, and the myrcene-threshold story is folklore [3][7] Disputed.
If you enjoy Sexxpot, that's fine — it's a pleasant, low-key flower. Just don't expect it to do something other moderate-THC indica hybrids won't.
Sources
- Practitioner Humboldt Seed Organization. Sexxpot strain page (breeder description).
- Reported Sullum, J. 'A Strain of Marijuana Designed for Women.' Reason / Forbes coverage of HSO's Sexxpot launch, 2015.
- Peer-reviewed Smith, C. J., et al. 'The phytochemical diversity of commercial Cannabis in the United States.' PLOS ONE, 2022.
- Peer-reviewed Lynn, B. K., López, J. D., Miller, C., Thompson, J., & Campian, E. C. 'The Relationship between Marijuana Use Prior to Sex and Sexual Function in Women.' Sexual Medicine, 7(2), 2019, 192-197.
- Peer-reviewed Wiebe, E., & Just, A. 'How Cannabis Alters Sexual Experience: A Survey of Men and Women.' Journal of Sexual Medicine, 16(11), 2019, 1758-1762.
- Peer-reviewed Cooper, Z. D., & Craft, R. M. 'Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective.' Neuropsychopharmacology, 43(1), 2018, 34-51.
- Peer-reviewed Piomelli, D., & Russo, E. B. 'The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD.' Cannabis and Cannabinoid Research, 1(1), 2016, 44-46.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Myrcene — The most common monoterpene in cannabis, blamed and credited for a lot of things it probab...